BioSante Pharmaceuticals Announces Lifting Of Clinical Hold On GVAX Prostate Cancer Vaccine
6/07/2011
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that the FDA's clinical hold on the GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been lifted by FDA. Manufacturing of new GVAX Prostate is complete, and planning for a Phase II clinical trial at the Johns Hopkins Kimmel Cancer Center is underway...
Link Between Pregnancy, Tumor Spread And Immune Cells
6/07/2011
Individuals with cancer often do not die as a result of their initial tumor but as a result of tumors at distant sites that are derived from the initial tumor. Pregnancy is a condition that seems to be permissive for tumor dissemination, as breast tumors arising during pregnancy display a tendency for early spread to distant sites (metastasis)...
Scientists presented new research at SNM's 58th Annual Meeting that has the potential to help physicians detect breast cancer by imaging the proliferation of blood vessels carrying oxygen and nutrients to breast tumors. Their study is evaluating a new imaging agent that is naturally drawn to angiogenesis - the development of new blood vessels in tissues both normal and cancerous...
Hidden Blood Clots Lit Up By Near Infrared Fluorescence
6/07/2011
Research presented at SNM's 58th Annual Meeting may mark the expansion of a novel imaging agent for an optical technique called near-infrared fluorescence (NIRF), which uses light energy to glean information about cells and tissues...
Molecular Imaging Helps Detect Whether Ovarian Tumors Are Cancerous Or Benign Prior To Surgery
6/07/2011
A study presented at SNM's 58th Annual Meeting may provide a new tool for detection of malignant-stage ovarian cancer...
Investigators at SNM's 58th Annual Meeting are presenting results from a phase 1 clinical trial for a cancer therapy that has the potential to kill colorectal tumors with less destruction of healthy tissue...
Superior Tumor Detection For Dense Breasts Provided By Gamma Imaging
6/07/2011
A study revealed at SNM's 58th Annual Meeting is comparing the breast-tumor detection capabilities of two very different imaging technologies - breast-specific gamma imaging (BSGI), which provides functional images of breast physiology, and ultrasound - for women with complex breast imaging cases that require further evaluation...
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; Cyclacel or the Company), today announced interim results from an ongoing, multicenter, Phase 1/2 clinical trial examining the safety and effectiveness of oral sapacitabine, the Company's lead product candidate, administered sequentially with decitabine. Thirty-day mortality from all causes was 4...
News From Annals Of Internal Medicine: June 7, 2011
6/07/2011
1. Smoking, Even for a Short Time, Significantly Increases a Woman's Risk for Peripheral Artery Disease A prospective study of initially healthy women aged 45 and over found that smoking is a potent risk factor for symptomatic peripheral artery disease, or PAD. PAD is a serious, often debilitating disorder, caused by narrowing of the arteries in the lower extremities...
Experts From The NYU Cancer Institute Present At ASCO 2011 Annual Meeting
6/07/2011
Experts from The Cancer Institute, an NCI-designated cancer center, at NYU Langone Medical Center presented new research findings at the 47th American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago, IL...